Skip to collection list Skip to video grid
Skip to collection list Skip to video grid

All Video Abstracts

RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing

This exploratory analysis from the phase 2/3 MEDLEY trial describes RSV neutralizing antibody levels associated with nirsevimab relative to palivizumab, the previous standard of care.

Read More
Read Less

categories

View more in
All Video Abstracts

Currently loaded videos are 1 through 15 of 752 total videos.

First page loaded, no previous page available
Load Next Page